The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | NET Cloudflare, Inc. | Michelle Zatlyn President and Board Co-Chair | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -33,003 | $0.00 | $0 | 957,087 | 6 d ago |
| Oct 5, 2026 | NET Cloudflare, Inc. | Michelle Zatlyn President and Board Co-Chair | MOption exercise Class B Common Stockderivative10b5-1 | +33,003 | $0.00 | $0 | 33,003 | 6 d ago |
| Oct 6, 2026 | NET Cloudflare, Inc. | Michelle Zatlyn President and Board Co-Chair | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -33,003 | $0.00 | $0 | 924,084 | 6 d ago |
| Oct 6, 2026 | NET Cloudflare, Inc. | Michelle Zatlyn President and Board Co-Chair | MOption exercise Class B Common Stockderivative10b5-1 | +33,003 | $0.00 | $0 | 33,003 | 6 d ago |
| Oct 7, 2026 | NET Cloudflare, Inc. | Michelle Zatlyn President and Board Co-Chair | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -33,003 | $0.00 | $0 | 891,081 | 6 d ago |
| Oct 7, 2026 | NET Cloudflare, Inc. | Michelle Zatlyn President and Board Co-Chair | MOption exercise Class B Common Stockderivative10b5-1 | +33,003 | $0.00 | $0 | 33,003 | 6 d ago |
| Oct 5, 2026 | MRNA Moderna, Inc. | James M Mock Chief Financial Officer | MOption exercise Common Stock | +1,454 | - | - | 60,829 | 6 d ago |
| Oct 5, 2026 | MRNA Moderna, Inc. | James M Mock Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -1,454 | $0.00 | $0 | 0 | 6 d ago |
| Oct 5, 2026 | IBTA Ibotta, Inc. | Bryan Leach CEO AND PRESIDENT | MOption exercise Class A Common Stock10b5-1 | +2,999 | $3.99 | $12k | 826,885 | 6 d ago |
| Oct 5, 2026 | IBTA Ibotta, Inc. | Bryan Leach CEO AND PRESIDENT | MOption exercise Class A Common Stock10b5-1 | +7,113 | $5.05 | $36k | 833,998 | 6 d ago |
| Oct 6, 2026 | IBTA Ibotta, Inc. | Bryan Leach CEO AND PRESIDENT | MOption exercise Class A Common Stock10b5-1 | +5,030 | $5.05 | $25k | 828,916 | 6 d ago |
| Oct 5, 2026 | IBTA Ibotta, Inc. | Bryan Leach CEO AND PRESIDENT | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -2,999 | $0.00 | $0 | 0 | 6 d ago |
| Oct 5, 2026 | IBTA Ibotta, Inc. | Bryan Leach CEO AND PRESIDENT | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -7,113 | $0.00 | $0 | 22,887 | 6 d ago |
| Oct 6, 2026 | IBTA Ibotta, Inc. | Bryan Leach CEO AND PRESIDENT | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -5,030 | $0.00 | $0 | 17,857 | 6 d ago |
| Oct 5, 2026 | CSTL CASTLE BIOSCIENCES INC | Derek J Maetzold Pres. & Chief Exec. Officer | MOption exercise Common Stock10b5-1 | +8,165 | $2.39 | $20k | 29,644 | 6 d ago |
| Oct 5, 2026 | CSTL CASTLE BIOSCIENCES INC | Derek J Maetzold Pres. & Chief Exec. Officer | MOption exercise Stock option (right to buy)derivative10b5-1 | -8,165 | $0.00 | $0 | 0 | 6 d ago |
| Oct 6, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Robert Hershberg director | MOption exercise Class A Common Stock10b5-1 | +25,000 | $2.22 | $56k | 187,156 | 6 d ago |
| Oct 6, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Robert Hershberg director | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -25,000 | $2.22 | $56k | 500,000 | 6 d ago |
| Oct 5, 2026 | PTCT PTC THERAPEUTICS, INC. | Mark Elliott Boulding EXEC. VP AND CLO | MOption exercise Common Stock10b5-1 | +1,638 | $39.42 | $65k | 106,910 | 6 d ago |
| Oct 6, 2026 | PTCT PTC THERAPEUTICS, INC. | Mark Elliott Boulding EXEC. VP AND CLO | MOption exercise Common Stock10b5-1 | +435 | $39.42 | $17k | 105,707 | 6 d ago |
| Oct 5, 2026 | PTCT PTC THERAPEUTICS, INC. | Mark Elliott Boulding EXEC. VP AND CLO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,638 | $0.00 | $0 | 2,894 | 6 d ago |
| Oct 6, 2026 | PTCT PTC THERAPEUTICS, INC. | Mark Elliott Boulding EXEC. VP AND CLO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -435 | $0.00 | $0 | 2,459 | 6 d ago |
| Oct 5, 2026 | INTA Intapp, Inc. | John T Hall Chief Executive Officer | MOption exercise Common Stock10b5-1 | +3,000 | $7.45 | $22k | 5,817,808 | 6 d ago |
| Oct 5, 2026 | INTA Intapp, Inc. | John T Hall Chief Executive Officer | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -3,000 | $0.00 | $0 | 61,000 | 6 d ago |
| Oct 6, 2026 | PALI PALISADE BIO, INC. | Mitchell Lawrence Jones See Remarks | MOption exercise Common Stock | +2,620,850 | - | - | 2,714,859 | 6 d ago |
| Oct 6, 2026 | PALI PALISADE BIO, INC. | Mitchell Lawrence Jones See Remarks | MOption exercise Restricted Stock Unitsderivative | -2,555,266 | $0.00 | $0 | 5,110,534 | 6 d ago |
| Oct 6, 2026 | PALI PALISADE BIO, INC. | Mitchell Lawrence Jones See Remarks | MOption exercise Restricted Stock Unitsderivative | -65,584 | $0.00 | $0 | 590,249 | 6 d ago |
| Oct 6, 2026 | PALI PALISADE BIO, INC. | John David Finley CEO CFO | MOption exercise Common Stock | +3,227,384 | - | - | 3,356,672 | 6 d ago |
| Oct 6, 2026 | PALI PALISADE BIO, INC. | John David Finley CEO CFO | MOption exercise Restricted Stock Unitsderivative | -3,059,800 | $0.00 | $0 | 6,119,600 | 6 d ago |
| Oct 6, 2026 | PALI PALISADE BIO, INC. | John David Finley CEO CFO | MOption exercise Restricted Stock Unitsderivative | -167,584 | $0.00 | $0 | 1,508,249 | 6 d ago |
| Oct 5, 2026 | GNRC GENERAC HOLDINGS INC. | Norman P Taffe President Generac Home | MOption exercise Common Stock10b5-1 | +100 | $119.54 | $12k | 11,076 | 6 d ago |
| Oct 6, 2026 | GNRC GENERAC HOLDINGS INC. | Norman P Taffe President Generac Home | MOption exercise Common Stock10b5-1 | +150 | $119.54 | $18k | 11,126 | 6 d ago |
| Oct 5, 2026 | GNRC GENERAC HOLDINGS INC. | Norman P Taffe President Generac Home | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -100 | $0.00 | $0 | 2,020 | 6 d ago |
| Oct 6, 2026 | GNRC GENERAC HOLDINGS INC. | Norman P Taffe President Generac Home | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -150 | $0.00 | $0 | 1,870 | 6 d ago |
| Oct 6, 2026 | CBNK Capital Bancorp Inc | Joshua Bernstein director | MOption exercise Common Stock | +561 | $26.41 | $15k | 91,470 | 6 d ago |
| Oct 6, 2026 | CBNK Capital Bancorp Inc | Joshua Bernstein director | MOption exercise Common Stock | +697 | $23.54 | $16k | 92,167 | 6 d ago |
| Oct 6, 2026 | CBNK Capital Bancorp Inc | Joshua Bernstein director | MOption exercise Common Stock | +850 | $24.20 | $21k | 93,017 | 6 d ago |
| Oct 6, 2026 | CBNK Capital Bancorp Inc | Joshua Bernstein director | MOption exercise Common Stock | +1,000 | $30.51 | $31k | 94,017 | 6 d ago |
| Oct 6, 2026 | CBNK Capital Bancorp Inc | Joshua Bernstein director | MOption exercise Stock Optionsderivative | -561 | $0.00 | $0 | 0 | 6 d ago |
| Oct 6, 2026 | CBNK Capital Bancorp Inc | Joshua Bernstein director | MOption exercise Stock Optionsderivative | -697 | $0.00 | $0 | 697 | 6 d ago |
| Oct 6, 2026 | CBNK Capital Bancorp Inc | Joshua Bernstein director | MOption exercise Stock Optionsderivative | -850 | $0.00 | $0 | 1,700 | 6 d ago |
| Oct 6, 2026 | CBNK Capital Bancorp Inc | Joshua Bernstein director | MOption exercise Stock Optionsderivative | -1,000 | $0.00 | $0 | 3,000 | 6 d ago |
| Oct 5, 2026 | LESLQ Leslie's, Inc. | Jeffrey Justin White See Remarks | MOption exercise Common Stock, par value $0.001 per share | +7,250 | $0.00 | $0 | 8,564 | 6 d ago |
| Oct 5, 2026 | LESLQ Leslie's, Inc. | Jeffrey Justin White See Remarks | MOption exercise Restricted Stock Unitsderivative | -7,250 | $0.00 | $0 | 28,375 | 6 d ago |
| Oct 5, 2026 | SOTK SONO TEK CORP | Christopher L Coccio CEO | MOption exercise SOTK Common Stock | +13,158 | $3.25 | $43k | 305,605 | 6 d ago |
| Oct 6, 2026 | SOTK SONO TEK CORP | Brian Lewis Booth Vice President | MOption exercise Sono-Tek Common Stock | +3,293 | $3.25 | $11k | 4,903 | 6 d ago |
| Oct 6, 2026 | SOTK SONO TEK CORP | Brian Lewis Booth Vice President | MOption exercise Sono-Tek Common Stock | +2,027 | $4.12 | $8,351 | 5,358 | 6 d ago |
| Oct 6, 2026 | SOTK SONO TEK CORP | R Stephen Harshbarger CEO | MOption exercise Sono-Tek Common Stock | +13,171 | $3.25 | $43k | 278,449 | 6 d ago |
| Oct 5, 2026 | SOTK SONO TEK CORP | Stephen James Bagley CFO | MOption exercise SonoTek Common Stock | +5,488 | $3.25 | $18k | 26,742 | 6 d ago |
| Oct 6, 2026 | MGNX MACROGENICS INC | Ezio Bonvini Sr VP, Research & CSO | MOption exercise Common Stock | +8,000 | $2.60 | $21k | 193,799 | 6 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.